Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia.
- Resource Type
- Article
- Source
- Vaccines; Apr2024, Vol. 12 Issue 4, p371, 13p
- Subject
CLINICAL trials IMMUNE response SARS-CoV-2 CELLULAR immunity ANTIBODY titer - Language
- ISSN
- 2076393X